Next Article in Journal
Application of Chromatographic and Electrophoretic Methods for the Analysis of Imidazolium and Pyridinium Cations as Used in Ionic Liquids
Previous Article in Journal
Full Analytic Progress Curves of Enzymic Reactions in Vitro
Int. J. Mol. Sci. 2006, 7(11), 485-496; doi:10.3390/i7110485

Triazoloquinazolines as Human A3 Adenosine Receptor Antagonists: A QSAR Study

1,* , 2 and 1,*
1 Systems Microbiology Research Center, KRIBB, Daejeon 305-806, Korea 2 Department of Biomicrosystem Technology, Korea University, Seoul 136-701, Korea 3 Department of Chemical and Biological Engineering, Korea University, Seoul 136-701, Korea
* Authors to whom correspondence should be addressed.
Received: 11 October 2006 / Accepted: 3 November 2006 / Published: 15 November 2006
View Full-Text   |   Download PDF [1104 KB, uploaded 19 June 2014]   |   Browse Figures


Multiple linear regression analysis was performed on the quantitative structure-activity relationships (QSAR) of the triazoloquinazoline adenosine antagonists for human A3receptors. The data set used for the QSAR analysis encompassed the activities of 33triazoloquinazoline derivatives and 72 physicochemical descriptors. A template moleculewas derived using the known molecular structure for one of the compounds when bound tothe human A2B receptor, in which the amide bond was in a cis-conformation. All the testcompounds were aligned to the template molecule. In order to identify a reasonable QSARequation to describe the data set, we developed a multiple linear regression program thatexamined every possible combination of descriptors. The QSAR equation derived from thisanalysis indicates that the spatial and electronic effects is greater than that of hydrophobiceffects in binding of the antagonists to the human A3 receptor. It also predicts that a largesterimol length parameter is advantageous to activity, whereas large sterimol widthparameters and fractional positive partial surface areas are nonadvatageous.
Keywords: QSAR; triazoloquinazoline adenosine antagonist; human A3 receptor. QSAR; triazoloquinazoline adenosine antagonist; human A3 receptor.
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Kim, D.; Hong, S.-I.; Lee, D.-S. Triazoloquinazolines as Human A3 Adenosine Receptor Antagonists: A QSAR Study. Int. J. Mol. Sci. 2006, 7, 485-496.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert